Donna Przepiorka

Statistics

Publications

160

Citations

27.8K

H-Index

Active since

1979

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

United States Food and Drug Administration

Baylor College of Medicine

Center for Drug Evaluation and Research

Fred Hutch Cancer Center

Donna Przepiorka is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and stem cell transplantation.

ORCID

Publications per year

1979–2024

160

Publications

160

1994 Consensus Conference on Acute GVHD Grading.

Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al. · PubMed · 1995 · 5.1K citations

Medicine, Internal Medicine, General Internal Medicine +6

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

Alexandra H. Filipovich, Daniel J. Weisdorf, Steven Z. Pavletic et al. · Biology of Blood and Marrow Transplantation · 2005 · 3.5K citations

Medicine, Pathology, Diagnostic Pathology +12

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Sergio Giralt, Elihu H. Estey, Maher Albitar et al. · Blood · 1997 · 1.2K citations · Full text

Medicine, Hematology, Oncology +16

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

Issa F. Khouri, Michael J. Keating, M Körbling et al. · Journal of Clinical Oncology · 1998 · 927 citations

Medicine, Immunology, Oncology +17

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Liang Li, Weishi Yuan et al. · The Oncologist · 2018 · 882 citations · Full text

Life Sciences, Immunology, Pharmacology +16

1–5 of 160